Serum anti‐Mullerian hormone levels across different ethnic groups: a cross‐sectional study

By  

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 122, Iss. 12, 2015-11 ,pp. : 1625-1629

John Wiley & Sons Inc

Access to resources Recommend Favorite

Do Lipid Lowering Drugs Reduce the Risk of Coronary Heart Disease?

By Pritzker L. B.  

Critical Reviews in Clinical Laboratory Sciences, Vol. 35, Iss. 6, 1998-12 ,pp. : 603-621

Informa Healthcare

Access to resources Recommend Favorite

The use of antithrombotic drugs for primary and secondary prevention of ischaemic stroke

By  

Reviews in Clinical Gerontology, Vol. 6, Iss. 4, 1996-11 ,pp. : 315-323

Cambridge University Press

Access to resources Recommend Favorite

Physicians’ attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regions

By Sposito Andrei C.   Ramires Jose A. F.   Jukema J. Wouter   Molina Juan Carlos   Silva Pedro Marques da   Ghadanfar Mathieu M.   Wilson Peter W. F.  

Current Medical Research and Opinion, Vol. 25, Iss. 5, 2009-05 ,pp. : 1171-1178

Informa Healthcare

Access to resources Recommend Favorite

Lipid-lowering drugs as primary prevention in general practice: Do patients reach guideline goals and continue treatment? ADDITION Denmark

By Graversen Lise   Christensen Bo   Borch-Johnsen Knut   Lauritzen Torsten   Sandbaek Annelli  

Scandinavian Journal of Primary Health Care, Vol. 29, Iss. 4, 2011-12 ,pp. : 216-221

Informa Healthcare

Access to resources Recommend Favorite